Mary L. Disis

Disis at the Cancer Vaccine Institute laboratory at the University of Washington

Mary L. "Nora" Disis is an American physician-oncologist whose research focuses on cancer immunotherapy and cancer vaccines. She is the editor-in-chief of JAMA Oncology and director of the Cancer Vaccine Institute at the University of Washington.

She was part of the scientific team who discovered that the HER2/neu molecule is a tumor-specific marker, or antigen.